Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-032501
Filing Date
2025-03-04
Accepted
2025-03-04 17:34:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5596
  Complete submission text file 0000950170-25-032501.txt   7422
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90744 | Film No.: 25706794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Filed by) CIK: 0001957515 (see all company filings)

EIN.: 131930701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A